John Dobak - 11 Mar 2022 Form 4 Insider Report for DermTech, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Issuer symbol
N/A
Transactions as of
11 Mar 2022
Net transactions value
-$19,293
Form type
4
Filing time
15 Mar 2022, 20:12:47 UTC
Previous filing
09 Mar 2022
Next filing
25 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale $19,293 -1,326 -0.3% $14.55* 446,549 11 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on June 25, 2020.